News & Updates

The Medicines and Healthcare products Regulatory Agency (MHRA) of the United Kingdom has granted marketing authorization for Quizartinib (Vanflyta) as first-line therapy in conjunction with standard chemotherapy for adult patients
The Medicines and Healthcare products Regulatory Agency (MHRA) in the UK has approved etrasimod (brand name Velsipity) for treating adults (over 16) with moderate to severe ulcerative colitis. This chronic
This article highlights a significant advancement in diabetes management with the FDA approval of Deka Research & Development's novel automated insulin pump, the twiist. Designed specifically for those living with
The FDA has approved a new medication called Tryvio (aprocitentan) for adults with high blood pressure that is difficult to control with existing therapies. Tryvio works differently than current medications
The Bill & Melinda Gates Medical Research Institute (Gates MRI) announced the start of a Phase 3 clinical trial to evaluate a new tuberculosis (TB) vaccine candidate, M72/AS01E. This is
As of today, 05-Feb-24, our community of A+ professionals is about to embark on an exciting journey of enhanced connectivity and knowledge exchange with Ladavius Network implementation! Our network is
On 21-Dec the EU authorities released a festive treat for those of us interested in the EU Clinical Trial Regulation - two new updates to guidance!